07/03/2025
3:10 PM | Lantern Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
6:43 PM | Bios Equity Partners, LP (Filed by)
Lantern Pharma (Subject)
| Form SCHEDULE 13D/A | |
06/13/2025
6:50 PM | BP Directors, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
6:57 PM | BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
5:06 AM | BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
5:01 AM | BP Directors, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
8:53 PM | BP Directors, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
8:55 PM | BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
7:55 PM | BIOS Fund I, LP (Reporting)
Lantern Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
7:56 PM | BIOS Fund II NT, LP (Reporting)
Lantern Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
7:58 PM | BIOS Fund I QP, LP (Reporting)
Lantern Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
8:00 PM | BIOS Fund II, LP (Reporting)
Lantern Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
7:53 PM | BIOS Fund II QP, LP (Reporting)
Lantern Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025
7:30 AM | Lantern Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
7:35 AM | Lantern Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025
7:56 PM | Lantern Pharma (Filer)
| Form 10-K/A | |
11/07/2024
8:09 PM | Lantern Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:15 PM | KEYSER D JEFFREY (Reporting)
Lantern Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
